Corentec Co

Corentec Co Rule of 40

The Rule of 40 of Corentec Co (104540.KQ) as of Oct 29, 2026 is 16.48 %. In the previous year, Rule of 40 was 4.72 % — a change of 249.07% (higher).

Rule of 40

16.48 %

YoY

249.07%

Last updated:

Rule of 40 of Corentec Co is 2025 16.48 % . Rule of 40 of Corentec Co was 2024 4.72 % . It decreases by 249.07% higher compared to the previous year.

The Corentec Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
-96.32 KRW
Jan 1, 2019
26.13 KRW
Jan 1, 2020
8.97 KRW
Jan 1, 2021
16.46 KRW
Jan 1, 2022
54.93 KRW
Jan 1, 2023
55.32 KRW
Jan 1, 2024
4.72 KRW
Jan 1, 2025
16.48 KRW
The Corentec Co Rule of 40 history
YEARRule of 40YoY
16.48 %+249.07%
4.72 %-91.47%
55.32 %+0.70%
54.93 %+233.75%
16.46 %+83.50%
8.97 %-65.68%
26.13 %-127.13%
-96.32 %+578.08%
-14.20 %-171.93%
19.75 %+13.73%
17.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Rule of 40 of Corentec Co is 16.48 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Corentec Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Corentec Co

All Key Metrics — Corentec Co